• Furosemide & Spironolactone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.

    Active IngredientStrengthPrimary Clinical Function
    Furosemide USP/Ph.Eur.20 mgThe Loop Diuretic (Fluid Clearance): Rapidly eliminates severe fluid buildup (edema) from the lungs, abdomen, and peripheral tissues.
    Spironolactone USP/Ph.Eur.50 mgThe Potassium-Sparing Shield: Blocks aldosterone, prevents toxic cardiac fibrosis, and heavily protects the patient against lethal hypokalemia.
    ExcipientsMicrocrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Slipper-Coating (Engineered utilizing advanced wet-granulation to ensure both the rapid-acting Furosemide and the slower-acting Spironolactone dissolve at precise, synchronized rates to guarantee the electrolyte-sparing synergy)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic cardiology and hepatology dispensing regimens).

  • Furosemide Injection

    Free

    Product Composition & Strength

    We supply this product as a Sterile Solution in Amber Glass Ampoules.

    Active IngredientStrengthVolume
    Furosemide USP/BP20 mg2 ml Ampoule (10 mg/ml) – Standard
    Furosemide USP/BP40 mg / 4 ml4 ml Ampoule – High Dose
    Furosemide USP/BP250 mg / 25 ml25 ml Vial – Renal Failure
    ExcipientsSodium Hydroxide / NaClpH Adjuster / Isotonicity

    *Pack Sizes: Tray of 10 Ampoules, 50 Ampoules, or 100 Ampoules.

  • Torsemide Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.

    Active IngredientStrengthPrimary Clinical Use
    Torsemide USP/Ph.Eur.5 mg / 10 mgStandard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension.
    Torsemide USP/Ph.Eur.20 mgAcute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations.
    Torsemide USP/Ph.Eur.100 mgHigh-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload.
    ExcipientsLactose Monohydrate / Crospovidone / Magnesium StearateDiluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)